AstraZeneca PLC (AZN) NYSE
187.14
+1.36(+0.73%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
187.14
+1.36(+0.73%)
Currency In USD
| Market Cap | 136.01B |
| Enterprise Value | 160B |
| P/E Ratio | 27.69 |
| PEG Ratio | 3.03 |
| Price/Sales Ratio | 4.83 |
| Price/Book Ratio | 5.9 |
| Enterprise/Revenue | 5.23 |
| Enterprise/EBITDA | 15.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.17 |
| Operating Margin | 0.23 |
| Return On Assets | 0.09 |
| Return On Equity | 0.23 |
| Revenue | 58.74B |
| Revenue/Share | 38.36 |
| Gross Profit | 48.11B |
| EBITDA | 19.83B |
| Net Income | 10.26B |
| Diluted EPS | 13.08 |
| Total Cash | 5.74B |
| Total Cash/Share | 3.7 |
| Total Debt | 29.7B |
| Total Debt/Equity | 0.61 |
| Current Ratio | 0.94 |
| Book Value Per Share | 31.41 |
| 52-Week Change | 30.5 |
| 52-Week High | 212.71 |
| 52-Week Low | 122.48 |
| Moving Average 50 Days | 193.92 |
| Moving Average 200 Days | 169.71 |
| Average Volume | 2.97M |
| Shares Outstanding | 775.14M |
| % Held by Institutions | 15.66 |
| Trailing Annual Dividend Rate | 3.16 |
| Trailing Annual Dividend Yield | 1.7 |
| Payout Ratio | 0.48 |
| Last Split Factor | 1:2 |
| Last Split Date | February 02, 2026 |